Sylvian Thepot
9PUBLICATIONS
129CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 08, 2025
Transplantation in patients with lower-risk MDS: a prospective phase 2 trial based on donor availability.Marie Sébert, Sylvain Thepot, Thomas Cluzeau
|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.Vincent Jachiet, Olivier Kosmider, Maxime Beydon
|May 07, 2025
Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS.Amy E DeZern, Sylvain Thepot, Stephane de Botton
|Apr 08, 2025
Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase 1b CIMON trial.Florent Malard, Sylvain Thepot, Thomas Cluzeau
|Dec 01, 2022
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.Raphael Itzykson, Valeria Santini, Sylvain Thepot
|Oct 06, 2022
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.Vincent Marmouset, Justine Decroocq, Sylvain Garciaz
Pageof 2
Frequent Collaborators
3 joint publications
Christian Récher
3 joint publications
Lionel Adès
2 joint publications
Eric Solary
2 joint publications
Mrinal M Patnaik
2 joint publications
Uwe Platzbecker
2 joint publications
Nathalie Droin
2 joint publications
Pierre-Yves Dumas
2 joint publications
Celine Berthon
2 joint publications
Gabriel Etienne
2 joint publications
Raphael Itzykson
